TABLE 2.
MLV and HIV Gag protein distributions in DRG neurons when coexpressed with a heterologous Env protein
Combination of recombinant SFV | Ratio of recombinant particlesa | Gag/Env ratio in cellsb | Coexpression frequency (%)c | % Coexpressing cells with Gag in soma and axon |
---|---|---|---|---|
SFV-1-gagMLV plus SFV-1-envHIV | 1:15 | 1:4 | 24 | 100 |
5:15 | 3:1 | 46 | 100 | |
10:15 | 1.6:1 | 44 | 100 | |
10:10 | NDd | 61 | 100 | |
SFV-1-gagHIV plus SFV-1-envMLV | 20:1 | 1:4 | NAe | 70 |
15:5 | 1:12 | NA | 62 | |
10:5 | 1:7 | NA | 60 |
Multiplicity of infection determined from titration on BHK-21 cells.
Determined from quantitation of radioactive proteins in SDS gels.
Stainings were with anti-MLV Gag antisera and anti-HIV antibodies for SFV-1-gagMLV plus SFV-1-envHIV and with anti-HIV Gag antibodies for SFV-1-gagHIV plus SFV-1-envMLV.
ND, not determined.
NA, not applicable.